" Knowing that I no longer have residual
disease would mean peace of mind."
Black Swan Research Initiative Updates
Understanding the Nature of MRD-Positive Myeloma
A study in the journal Blood reports for the first time the biological features of MRD (minimal
iStopMM (Iceland Screens Treats or Prevents Multiple Myeloma) really will stop myeloma for a whole country—Iceland!
As announced this week, the IMF is funding the iStopMM (Iceland Screens Treats or Prevents
Black Swan Research Initiative: 2016 Perspectives from Researchers, Patients, Supporters
The Black Swan Research Initiative is the IMF's groundbreaking and collaborative project aimed at
The Black Swan Research Initiative Is the “Myeloma Moonshot”
Many of the approaches to curing cancer Vice President Joe Biden advocates as part of the
Black Swan Research Initiative Update – Nov. 17, 2015
The Black Swan Research Initiative® (BSRI®), the International Myeloma Foundation’s innovative
Understanding the Nature of MRD-Positive Myeloma
A study in the journal Blood reports for the first time the biological features of MRD (minimal residual disease) cells in myeloma and shows that clonal selection is already present at the MRD stage.
iStopMM (Iceland Screens Treats or Prevents Multiple Myeloma) really will stop myeloma for a whole country—Iceland!
As announced this week, the IMF is funding the iStopMM (Iceland Screens Treats or Prevents Multiple Myeloma) study, an exciting new addition to the portfolio of more than 35 Black Swan Research
Black Swan Research Initiative: 2016 Perspectives from Researchers, Patients, Supporters
The Black Swan Research Initiative is the IMF's groundbreaking and collaborative project aimed at developing the first definitive cure for
The Black Swan Research Initiative Is the “Myeloma Moonshot”
Many of the approaches to curing cancer Vice President Joe Biden advocates as part of the much-discussed “cancer moonshot” have been part of the IMF’s Black Swan Research Initiative since its
Black Swan Research Initiative Update – Nov. 17, 2015
The Black Swan Research Initiative® (BSRI®), the International Myeloma Foundation’s innovative approach to finding a cure for myeloma, has entered a very exciting time. The project’s first
What is the latest news about the Black Swan Research Initiative?
In this week's video, Dr. Brian Durie gives an update on the IMF's signature research project, Black Swan Research Initative. Bottom Line: The BSRI team is expanding worldwide and exciting
Black Swan Research Initiative® Update – July 23, 2015
The Black Swan Research Initiative® (BSRI) is on the brink of several key steps forward, I am happy to report. Great progress has already been made. The Next Generation Flow (NGF) test has been
Whats the latest update on the Black Swan Research Initiative®?
In this week's video, Dr. Brian Durie gives an update on the exciting developments happening on the Black Swan Research
Freelite® and Hevylite® will help the Black Swan Research Initiative find the best treatment to cure multiple myeloma
Binding Site, a Birmingham, UK, based In-Vitro clinical diagnostic company, is pleased to announce that it has been chosen as an important diagnostic partner in the Black Swan ‘cure myeloma’
The IMF and the Euroflow Consortium Introduce Breakthrough in Detection of Minimal Residual Disease (MRD)
North Hollywood, CA, March 18, 2014 – The International Myeloma Foundation (IMF), in collaboration with the Europe-based EuroFlow consortium, will introduce a new automated and highly sensitive
